Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: Effect on expression in transfected glial and liver cell lines and plasma ACT concentrations

Human Genetics

Volumn 109, Issue 3, 2001, Pages 303-310

  Morgan, K ^a   Licastro, F ^a   Tilley, L ^a   Ritchie, A ^a   Morgan, L ^a   Pedrini, S ^a   Kalsheker, N ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; CYTOKINE; ONCOSTATIN M; SERINE PROTEINASE INHIBITOR;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; CELL STIMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENILE PLAQUE;

AGED; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; BASE SEQUENCE; CELL LINE; DNA; FEMALE; GENE EXPRESSION; GENES, REPORTER; HEPATOCYTES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEUROGLIA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSFECTION;

EID: 0034816125     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390100575     Document Type: Article

References (39)

1. Immunochemical identification of the serine protease inhibitor alpha1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 Å resolution and its comparison with other serpins
3. Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells
4. Regulation of alpha 1-antichymotrypsin synthesis in cells of epithelial origin
5. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
6. Alzheimer's disease risk in relation to α1-antichymotrypsin and apolipoprotein E polymorphism in very old adults age 75+
7. Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy
8. Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation
9. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population
10. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes
11. No genetic effect of alpha1-antichymotrypsin in Alzheimer disease
12. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: A report on autopsy-confirmed cases
13. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin
14. Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate
15. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism
16. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes
17. Mechanism of interleukin-1 and tumor necrosis factor α-dependent regulation of α1-antichymotrypsin gene in human astrocytes
18. New core promoter element in RNA polymerase II-dependent transcription: Sequence-specific DNA binding by transcription factor IIB
19. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases
20. Liver provides bulk of increase in circulating ACT following cytokine stimulation
21. Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype
22. A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease
23. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
24. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: Peripheral inflammation or signals from the brain?
25. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk
26. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments
27. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
28. Astroglial expression of human alpha (1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
29. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease
30. Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease
31. Presence of alpha1-antichymotrypsin and alpha1-antitrypsin in haematopoietic and lymphoid tissue cells as revealed by the immunoperoxidase method
32. T98G: An anchorage-independent human cell line that exhibits stationary phase G1 arrest in vitro
33. Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome
34. Human plasma proteinase inhibitors
35. Alpha (1)-antichymotrypsin gene polymorphism in patients with stroke
36. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy
37. Alpha 1-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers